Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Receivables - Net: 2019-2022

Historic Receivables - Net for Bicycle Therapeutics (BCYC) over the last 4 years, with Dec 2022 value amounting to $2.0 million.

  • Bicycle Therapeutics' Receivables - Net was N/A to $136,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $136,000, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2022, which is 104.50% up from last year.
  • Bicycle Therapeutics' Receivables - Net amounted to $2.0 million in FY2022, which was up 104.50% from $1.0 million recorded in FY2021.
  • Bicycle Therapeutics' Receivables - Net's 5-year high stood at $5.5 million during FY2020, with a 5-year trough of $201,000 in FY2019.
  • In the last 3 years, Bicycle Therapeutics' Receivables - Net had a median value of $2.0 million in 2022 and averaged $2.8 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 2,614.43% in 2020, then crashed by 81.67% in 2021.
  • Yearly analysis of 4 years shows Bicycle Therapeutics' Receivables - Net stood at $201,000 in 2019, then surged by 2,614.43% to $5.5 million in 2020, then crashed by 81.67% to $1.0 million in 2021, then spiked by 104.50% to $2.0 million in 2022.